Levaquin is the Preferred Quinolone Among More Than Half of All General Medical-Surgical Hospitals in the United States
Posted on: Tuesday, 2 December 2008, 07:00 CST
"Based on our
The newly released edition of the Quinolone Monthly Monitor (U.S.) also finds that over 70 percent of hospitals reported having a closed hospital formulary for antibiotics. Large hospitals were found to be most likely to have a closed formulary for antibiotics. These closed formularies create restrictions on what can be prescribed in the hospital making it more difficult for a prescriber to use that medication.
Why Pharmaceutical Companies Need this Information
The Quinolone Monthly Monitor (U.S.) enables pharmaceutical companies to monitor formulary, stocking and restriction status of selected quinolone antibiotics. This study also gives information about the Pharmacy and Therapeutics Committee's actions for quinolones, which drive formulary and restriction status for these products.
About The Quinolone Monthly Monitor (U.S.)
The Quinolone Monthly Monitor (U.S.) is the industry's most comprehensive
market research study of the formulary status of quinolone antibiotics. This
study has been conducted monthly since
About AMR
AMR (http://www.AMR-data.com) serves the market intelligence needs of the pharmaceutical and diagnostic imaging industries. Research includes clinical inpatient databases that directly link anti-infective drug with indication/procedure, formulary and stocking status tracking studies, drug purchasing audits and diagnostic imaging procedure volume/contrast media usage audits. AMR is a Decision Resources, Inc. company.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.
All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.
Natalia Morales Elizabeth Marshall Decision Resources Decision Resources, Inc. 781-296-2691 781-296-2563 nmorales@dresources.com emarshall@dresources.comSOURCE Arlington Medical Resources
Source: PR Newswire
Related Articles
- Arena Resources Announces Record Third Quarter and Nine Month 2008 Financial and Operating Results
- Arena Resources Announces Record Second Quarter and Six Month 2008 Financial and Operating Results
- Most Hospital Pharmacy and Therapeutics Committee Members Anticipate That Drugs From Johnson & Johnson/Basilea and Theravance/Astellas Will Achieve Formulary Inclusion Among Hospitals but With Restrictions
- Equipping Your Sales Force to Influence Hospital Formulary Decision-Makers
- Building an Effective Sales Force to Influence Formulary Decision-Makers in the U.S. Hospital Marketplace
- Hospital Sales Force Effectiveness: Hiring, Training and Deploying a Sales Force to Effectively Target Future Formulary Decision-Makers
- Hospital Sales Force Effectiveness: Hiring, Training and Deploying a Sales Force to Effectively Target IDN and GPO Formulary Decision Makers
- Decision Resources Forecasts the Five Drugs That Will Achieve Blockbuster Status During the Next Decade
- Arena Resources Announces Record Third Quarter and Nine-Month 2005 Financial and Operating Results
- Bluffs Hospital Given Special Status
 |
 |
User Comments (0)
RSS Feeds